期刊文献+

单核苷酸多态性与乳腺癌化疗应答 被引量:1

Single Nucleotide Polymorphism and Chemotherapy Response of Breast Cancer
下载PDF
导出
摘要 目的探讨单核苷酸多态性(SNP)与乳腺癌常规化疗药物治疗应答间的相关性及其在指导个体化治疗中的价值。方法检索Pub-Medline和中国CHKD期刊数据库,对近年来此领域有代表性的文献进行整理、归纳。结果多种药物代谢相关基因存在SNP现象,且与药物效应个体多样性有着密切联系。人种、地域、环境、基因间或药物间相互作用可能会对这种关系产生影响。结论SNP研究对于优化个体用药具有重要的应用前景,但多基因多SNP组合分析以及大样本、前瞻性随机对照研究还非常必要。 Objective To investigate the relationship between single nueleotide polymorphism (SNP) and therapy response of some conventional chemotherapy drugs in breast cancer, and to explore the value of SNP in guiding individualized treatment. Methods Pub-Medline and Chinese CHKD periodical electronic databases were searched. Representative researches in this field were sorted out and concluded. Results Varied genes related to drug metabolism have SNP phenomenon, which are closely associated with interindividual diversity in drug response. Race, section, environment, and drug-drug or gene-gene interactions may have effect on the association. Conclusion The study on SNP has important application prospect in optimizing the individual drug-delivery. However, the combinatorial analyses of rnulti-SNPs and multi genes and the prospective studies with large scale samples and random controls are still needed,
出处 《中国普外基础与临床杂志》 CAS 2008年第12期950-953,共4页 Chinese Journal of Bases and Clinics In General Surgery
基金 江苏省社会发展科技计划项目(项目编号:BS2007077) 江苏省社会发展计划重点招标项目(项目编号:BS2006006)~~
关键词 多态性 化疗 个体化治疗 乳腺癌 Polymorphism Chemotherapy Individualized treatment Breast cancer
  • 相关文献

参考文献29

  • 1International HapMap Consortium. A haplotype map of the human genome [J]. Nature, 2005; 437(7063)∶ 1299
  • 2Giacomini KM, Brett CM, Altman RB, et al. The pharmacogenetics research network: from SNP discovery to clinical drug response [J]. Clin Pharmacol Ther, 2007; 81(3)∶ 328
  • 3Choi JY, Nowell SA, Blanco JG, et al. The role of genetic variability in drug metabolism pathways in breast cancer prognosis [J]. Pharmacogenomics, 2006; 7(4)∶ 613
  • 4Kim SJ, Noguchi S. Prediction of response to docetaxel in breast cancer [J]. Gan To Kagaku Ryoho, 2008; 35(2)∶ 190
  • 5Marsh S, Somlo G, Li X, et al. Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancer [J]. Pharmacogenomics J, 2007; 7(5)∶362
  • 6Nakajima M, Fujiki Y, Kyo S, et al. Pharmacokinetics of paclitaxel in ovarian cancer patients and genetic polymorphisms of CYP2C8, CYP3A4, and MDR1 [J]. J Clin Pharmacol, 2005; 45(6)∶ 674
  • 7范伟,杨金巧,伍晓汀.乳腺浸润性导管癌中PS2和GSTπ的表达及临床意义[J].中国普外基础与临床杂志,2004,11(1):14-16. 被引量:3
  • 8Medeiros R, Pereira D, Afonso N, et al. Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome [J]. Int J Clin Oncol, 2003; 8(3)∶ 156
  • 9Sweeney C, McClure GY, Fares MY, et al. Association between survival after treatment for breast cancer and glutathione S-transferase P1 Ile105Val polymorphism [J]. Cancer Res, 2000; 60(20)∶5621
  • 10Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo [J]. Proc Natl Acad Sci USA, 2000; 97(7)∶ 3473

二级参考文献26

  • 1陈高明 李春海.乳腺癌中GSTπ和MDR1基因表达及其临床价值[J].中国癌症研究进展,1998,5(6):81-81.
  • 2Zhou J, Cheng SC, Luo D, et al. Study of multi-drug resistant mechanisms in a taxol-resistant hepatocellular carcinoma QGY-TR 50 cell line. Biochem Biophys Res Commun, 2001,280(5) : 1237-1242.
  • 3Kamath K, Wilson L, Cabral F, et al. BetaⅢ-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability. J Biol Chem, 2005, 280 ( 13 ) : 12902-12907.
  • 4Dumontet C, Isaac S, Souquet PJ, et al. Expression of class Ⅲ beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy. Bull Cancer, 2005,92 (2) : E25-30.
  • 5Mozzetti S, Ferlini C, Concolino P, et al. Class Ⅲ beta- tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin Cancer Res, 2005,11 ( 1 ) :298-230.
  • 6Kavallaris M, Tait AS, Walsh BJ, et al. Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. Cancer Res,2001,61 (15) : 5803-5809.
  • 7Don S, Verrills NM, Liaw TY, et al. Neuronal-associated microtubule proteins class Ⅲ beta-tuliulin and MAP2c in neuroblastoma: role in resistance to microtubule-targeted drugs. Mol Cancer Ther, 2004,3(9) : 1137-1146.
  • 8Sirotnak FM, Danenberg KD, Chen J, et al. Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression of alpha and beta tubulin isoforms. Biochem Biophys Res Commun, 2000,269( 1 ) :21-24.
  • 9Dumontet C, Jaffrezou JP, Tsuchiya E, et al. Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization. Bull Cancer,2004,91(5) :E81-112.
  • 10He L, Yang CP, Horwitz SB. Mutations in beta-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines. Mol Cancer Ther, 2001,1 (1) :3-10.

共引文献3

同被引文献2

  • 1Rui Medeiros,Deolinda Pereira,Noémia Afonso,Carlos Palmeira,Cristina Faleiro,Carlos Afonso-Lopes,Margarida Freitas-Silva,André Vasconcelos,Sandra Costa,Teresa Osório,Carlos Lopes. Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome[J] 2003,International Journal of Clinical Oncology(3):156~161
  • 2刘东华,章霞芝,陈兴无,张帆,陆志伟,金艺风,卢林明.survivin、MDR_1、MRP在非小细胞肺癌中的表达及意义[J].实用肿瘤杂志,2008,23(2):126-129. 被引量:7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部